
Nkarta Therapeutics Presents Preclinical Data for CD19 CAR NK Program
SOUTH SAN FRANCISCO, Calif., Nov. 18, 2019 (GLOBE NEWSWIRE) -- Nkarta Therapeutics, a privately-held biopharmaceutical company developing engineered natural killer (NK) cell therapies to fight cancer, today announced preclinical data were presented in a …